Can-Fite to Initiate Phase II Study in the Rare Genetic Disease Lowe Syndrome with Piclidenoson
FDA & EMA approvals for rare genetic diseases are fast and require clinical studies with small number of patients Ramat Gan, Israel, March ...
新浪网24 天
“星际之门”AI基建项目启航！得州首座数据中心拟部署6.4万颗英伟 ...
智通财经APP获悉，OpenAI和甲骨文(OCRL.US)计划在未来数月内，在美国得克萨斯州一处新建的大型数据中心部署数万颗英伟达(NVDA.US)的高性能AI芯片 ...
新浪网24 天
“星际之门”AI基建项目启航！得州首座数据中心拟部署6.4万颗英伟 ...
OpenAI和甲骨文(OCRL.US)计划在未来数月内，在美国得克萨斯州一处新建的大型数据中心部署数万颗英伟达(NVDA.US)的高性能AI芯片，这是其耗资1000亿美元 ...
eLife4 年
A genome engineering resource to uncover principles of cellular organization and tissue ...
Phosphoinositides (PI) are key regulators of cellular organization in eukaryotes and genes that tune PI signaling are implicated in human disease mechanisms. Biochemical analyses and studies in ...
eLife10 年
A role of OCRL in clathrin-coated pit dynamics and uncoating revealed by studies of Lowe ...
Mutations in the inositol 5-phosphatase OCRL cause Lowe syndrome and Dent's disease. Although OCRL, a direct clathrin interactor, is recruited to late-stage clathrin-coated pits, clinical ...